Breaking the harmony of TNF-α signaling for cancer treatment

Oncogene

Volumn 31, Issue 37, 2012, Pages 4117-4127

  Sasi, S P ^a,b   Yan, X ^b,c   Enderling, H ^a,c   Park, D ^b   Gilbert, H Y ^a,b   Curry, C ^b   Coleman, C ^b   Hlatky, L ^a,c   Qin, G ^d   Kishore, R ^d   Goukassian, D A ^a,b,c  

^a Center of Cancer Systems Biology   (United States)

^b Steward St Elizabeth's Medical Center   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

angiogenesis; cancer; EPC; microenvironment; TNF ; TNFR2 p75

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PLACENTAL GROWTH FACTOR; PROTEIN P55; PROTEIN P75; SCATTER FACTOR; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CAPILLARY DENSITY; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; KNOCKOUT MOUSE; LEWIS CARCINOMA; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; WILD TYPE;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL12; HEPATOCYTE GROWTH FACTOR; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREGNANCY PROTEINS; RECEPTORS, CXCR4; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTORS;

MURINAE; MUS;

EID: 84866372364     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.567     Document Type: Article

References (47)

1. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H et al. (1999). VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972. (Pubitemid 29335849)
2. Barbara JA, Van ostade X, Lopez A. (1996). Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective. Immunol Cell Biol 74: 434-443. (Pubitemid 26342128)
3. Bhardwaj A, Aggarwal BB. (2003). Receptor-mediated choreography of life and death. J Clin Immunol 23: 317-332. (Pubitemid 37083187)
4. Coleman C, Levine D, Kishore R, Qin G, Thorne T, Lambers E et al. (2010). Inhibition of melanoma angiogenesis by telomere homolog oligonucleotides. J Oncol 2010: 928628.
5. De Plaen IG, Han XB, Liu X, Hsueh W, Ghosh S, May MJ. (2006). Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor. Immunology 118: 153-163. (Pubitemid 43727420)
6. Eisenthal A, Schwartz I, Issakov J, Klausner Y, Misonzhnik F, Lifschitz-Mercer B. (2003). Immunohistochemistry evaluation of the effect in vivo of tumor necrosis factor (TNF)-alpha on blood vessel density in murine fibrosarcoma. Sarcoma 7: 57-61. (Pubitemid 37076303)
7. Elbaz O, Mahmoud LA. (1994). Tumor necrosis factor and human acute leukemia. Leuk Lymphoma 12: 191-195. (Pubitemid 24077167)
8. Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC. (1992). Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 140: 539-544.
9. Fiers W, Beyaert R, Boone E, Cornelis S, Declercq W, Decoster E et al. (1995). TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm 47: 67-75.
10. Folkman J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
11. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P. (1987). Tumor necrosis factor a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84: 5277-5281. (Pubitemid 17129009)
12. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. (2008). Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198.
13. Gimbrone Jr MA, Leapman SB, Cotran RS, Folkman J. (1972). Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261-276.
14. Goillot E, Combaret V, Ladenstein R, Baubet D, Blay JY, Philip T et al. (1992). Tumor necrosis factor as an autocrine growth factor for neuroblastoma. Cancer Res 52: 3194-3200.
15. Goukassian DA, Qin G, Dolan C, Murayama T, Silver M, Curry C et al. (2007). Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 115: 752-762. (Pubitemid 46294766)
16. Gupta S, Chiplunkar S, Kim C, Yel L, Gollapudi S. (2003). Effect of age on molecular signaling of TNF-alpha-induced apoptosis in human lymphocytes. Mech Ageing Dev 124: 503-509. (Pubitemid 36514905)
17. Hanahan D, Folkman J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364. (Pubitemid 26272076)
18. Hohenberger P, Latz E, Kettelhack C, Rezaei AH, Schumann R, Schlag PM. (2003). Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. Ann Surg Oncol 10: 562-568. (Pubitemid 40486921)
19. Jacobsen SE, Jacobsen FW, Fahlman C, Rusten LS. (1994). TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis. Stem Cells 12(Suppl 1): 111-126 discussion 126-8.
20. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E et al. (2000). Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202. (Pubitemid 30436658)
21. Kohno K, Kurimoto M. (1998). Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol 86: 11-15. (Pubitemid 28055722)
22. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A et al. (1993). Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 53: 1982-1985. (Pubitemid 23145713)
23. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. (1987). Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329: 630-632. (Pubitemid 17140112)
24. Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB, Young PP. (2009). Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res 69: 338-348.
25. Liu RY, Fan C, Mitchell S, Chen Q, Wu J, Zuckerman KS. (1998). The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-alpha to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e. Cancer Res 58: 2217-2223. (Pubitemid 28232911)
26. Luo D, Luo Y, He Y, Zhang H, Zhang R, Li X et al. (2006). Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Am J Pathol 169: 1886-1898. (Pubitemid 351182017)
27. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L et al. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7: 1194-1201. (Pubitemid 33063774)
28. Madge LA, Pober JS. (2001). TNF signaling in vascular endothelial cells. Exp Mol Pathol 70: 317-325. (Pubitemid 32607204)
29. Meng Y, Beckett MA, Liang H, Mauceri HJ, van Rooijen N, Cohen KS et al. (2010). Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. Cancer Res 70: 1534-1543.
30. Montesano R, Soulie P, Eble JA, Carrozzino F. (2005). Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells. J Cell Sci 118: 3487-3500. (Pubitemid 41246102)
31. Mukhopadhyay A, Suttles J, Stout RD, Aggarwal BB. (2001). Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages. J Biol Chem 276: 31906-31912.
32. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE. (2001). Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167: 1644-1653. (Pubitemid 32703167)
33. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC et al. (2005). Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11: 261-262. (Pubitemid 40460552)
34. Rafii S, Lyden D. (2008). Cancer. A few to flip the angiogenic switch. Science 319: 163-164.
35. Riccardi C, Nicoletti I. (2006). Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1: 1458-1461.
36. Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M et al. (2008). TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways. Exp Cell Res 314: 509-529.
37. Rothe M, Wong SC, Henzel WJ, Goeddel DV. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78: 681-692. (Pubitemid 24268590)
38. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K et al. (1996). Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271: 28220-28228. (Pubitemid 26374633)
39. Santarelli JG, Udani V, Yung YC, Cheshier S, Wagers A, Brekken RA et al. (2006). Incorporation of bone marrow-derived Flk-1-expres-sing CD34+ cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery 59: 374-382 discussion-82.
40. Sato N, Fukuda K, Nariuchi H, Sagara N. (1987). Tumor necrosis factor inhibiting angiogenesis in vitro. J Natl Cancer Inst 79: 1383-1391. (Pubitemid 18036745)
41. Sethi G, Sung B, Aggarwal BB. (2008). TNF: a master switch for inflammation to cancer. Front Biosci 13: 5094-5107. (Pubitemid 351599660)
42. Slowik MR, De Luca LG, Fiers W, Pober JS. (1993). Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol 143: 1724-1730. (Pubitemid 24058275)
43. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H. (1999). Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 159: 4516-4518. (Pubitemid 29428949)
44. Vandenabeele P, Declercq W, Beyaert R, Fiers W. (1995). Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5: 392-399.
45. Wong GH, Goeddel DV. (1994). Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 152: 1751-1755. (Pubitemid 24075706)
46. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H et al. (1997). Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17: 4015-4023. (Pubitemid 27281877)
47. Zhang R, Xu Y, Ekman N, Wu Z, Wu J, Alitalo K et al. (2003). Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J Biol Chem 278: 51267-51276. (Pubitemid 38020364)